Logo 577 750 Pill - yellow oval, 20mm
Pill with imprint Logo 577 750 is Yellow, Oval and has been identified as Metformin Hydrochloride Extended-Release 750 mg. It is supplied by Watson Pharmaceuticals.
Metformin is used in the treatment of Diabetes, Type 2 and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 577 750
Metformin Hydrochloride Extended-Release
- Imprint
- Logo 577 750
- Strength
- 750 mg
- Color
- Yellow
- Size
- 20.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Non-sulfonylureas
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- Inactive Ingredients
-
hypromellose 2208 (15000 mPa.s),
silicon dioxide,
D&C Yellow No. 10,
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 62037-0577 (Discontinued) | Watson Pharmaceuticals, Inc. |
| 60429-0280 | Golden State Medical Supply (repackager) |
More about metformin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (650)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: non-sulfonylureas
- Breastfeeding
Patient resources
- Metformin drug information
- Metformin Extended-Release Suspension
- Metformin Extended-Release Tablets
- Metformin Tablets
- Metformin Oral Solution
Other brands
Glucophage, Glumetza, Glucophage XR, Fortamet, ... +2 more
Professional resources
- MetFORMIN monograph
- Metformin (FDA)
- Metformin Aerosol (FDA)
- Metformin Extended Release Tablet (FDA)
- Metformin Extended Release Tablets (FDA)
- Metformin Oral Solution (FDA)
Other brands
Glucophage, Glumetza, Glucophage XR, Fortamet, Riomet
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
